Detalles de la búsqueda
1.
TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial.
Lancet Oncol
; 17(2): 212-223, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26727163
2.
Optimal line of hepatotomy for left lateral living donor liver transplantation according to the anatomical variations of left hepatic duct system.
Pediatr Transplant
; 19(5): 510-6, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25907302
3.
Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial.
Lancet Oncol
; 12(12): 1125-33, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22019520
4.
Lung cancer in smoking patients inversely alters the activity of hOGG1 and hNTH1.
Cancer Lett
; 219(2): 191-5, 2005 Mar 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-15723719
5.
Sunitinib plus erlotinib versus placebo plus erlotinib in patients with previously treated advanced non-small-cell lung cancer: a phase III trial.
J Clin Oncol
; 30(17): 2070-8, 2012 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-22564989
6.
Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer.
J Clin Oncol
; 25(15): 2086-92, 2007 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-17513814
7.
Open-label, multicenter, randomized, phase III study comparing oral topotecan/cisplatin versus etoposide/cisplatin as treatment for chemotherapy-naive patients with extensive-disease small-cell lung cancer.
J Clin Oncol
; 24(13): 2044-51, 2006 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16648504
Resultados
1 -
7
de 7
1
Próxima >
>>